통증 패치 시장 : 유형별, 용도별, 기술별, 제형별, 처방별, 환자 연령별, 점착 특성별, 작용 시간별, 약제 클래스별, 유통 채널별, 지역별

Pain Patch Market, By Type, By Application, By Technology, By Formulation, By Prescription, By Patient Age, By Adhesive Properties, By Duration of Action, By Drug Class, By Distribution Channel, By Geography

US $ 4,500 ￦ 6,458,000

Unprintable PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 7,000 ￦ 10,046,000

PDF & Excel (Multi User License - Up to 7 Users)

PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,352,000

PDF & Excel (Corporate User License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

통증 패치 시장은 2025년에는 58억 3,000만 달러로 추정되고, 2032년에는 82억 달러에 이를 것으로 예상되며, 2025-2032년 CAGR 5%로 성장이 예측되고 있습니다.

보고 범위		보고서 세부정보
기준 연도	2024년	시장 규모(2025년)	58억 3,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간 CAGR(2025-2032년) :	5.00%	예측 금액(2032년)	82억 달러

통증 패치는 경피 패치로도 알려져 있으며 국소 통증을 완화하기 위해 피부에서 직접 약물을 전달하는 접착 패치입니다. 이러한 패치는 편리하고 사용하기 쉬우며 장기간에 걸쳐 약물 방출을 제어할 수 있습니다.

시장 역학 :

통증 패치 시장은 주로 관절염, 요통, 신경 병증 통증과 같은 만성 통증 증상의 유병률이 증가함에 따라 견인되고 있습니다. 이러한 질환에는 장기적인 통증 관리 솔루션이 필요하며, 통증 패치는 편리하고 효과적인 선택지를 제공합니다. 게다가 중독이나 위장의 부작용 등 경구 진통제와 관련된 잠재적인 위험에 대한 의식의 고조로 통증 패치와 같은 비침습적 약물 전달 시스템에 대한 주목이 높아지고 있습니다.

그러나, 시장 성장의 방해가 되는 요인도 있습니다. 기존 진통약에 비해 통증 패치의 비용이 높고, 일부 지역에서는 이러한 제품에 대한 상환이 한정되어 있는 것이, 시장의 확대를 제한할 가능성이 있습니다. 또한, 통증 패치의 승인에는 엄격한 규제 요건이 있어, 패치의 사용에 수반하는 피부 자극이나 알레르기 반응의 위험이 시장 성장의 과제가 되고 있습니다.

이러한 과제에도 불구하고 통증 패치 시장에는 몇 가지 성장 기회가 있습니다. 통증 패치에서의 무선 연결과 센서 통합 등 첨단 기술의 채택이 증가하고 있기 때문에 기술 혁신 및 제품 차별화의 길이 열려 있습니다. 나아가 신흥 시장의 미개척 가능성과 개별화된 통증 관리 솔루션에 대한 수요의 증대는 시장 기업이 존재감을 확대하고 다양한 소비자층에 대응할 기회를 제공합니다.

본 조사의 주요 특징

• 본 보고서에서는 세계의 통증 패치 시장을 상세하게 분석했으며, 2024년을 기준연도로 한 예측 기간(2025-2032년) 시장 규모 및 복합 연간 성장률(CAGR%)을 제공합니다.
• 또, 다양한 부문에 걸친 잠재적인 수익 기회를 해명해, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
• 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 세계 통증 패치 시장의 주요 기업을 프로파일 하고 있습니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자나 기업의 경영진은 장래의 제품 발매, 유형 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
• 세계의 통증 패치 시장 보고서는 투자자, 공급자, 제품 제조업체, 유통업체, 신규 참가자, 재무 애널리스트 등, 이 업계의 다양한 이해 관계자에 대응하고 있습니다.
• 이해관계자는 세계의 통증 패치 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

목차

제1장 조사 목적 및 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의 및 범위
• 주요 요약
• 일관된 기회 지도(COM)

제3장 시장 역학, 규제 및 동향 분석

• 시장 역학
  • 효과적인 통증 완화 및 비침습적인 치료에 대한 수요 증가
  • 피부의 민감성 및 염증
  • 개별화된 통증 관리 출현
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 출시 및 승인
• PEST 분석
• Porter's Five Forces 분석
• 합병 및 인수 시나리오

제4장 통증 패치 시장 : 코로나 바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측 및 수요측 분석
• 경제에 미치는 영향

제5장 통증 패치 시장 : 유형별(2020-2032년)

• 오피오이드
• 비오피오이드

제6장 통증 패치 시장 : 용도별(2020-2032년)

• 만성 통증
• 급성 통증

제7장 통증 패치 시장 : 기술별(2020-2032년)

• 기존 약물 전달 패치
• 첨단 약물 전달 패치

제8장 통증 패치 시장 : 제형별(2020-2032년)

• 단제
• 병용 요법

제9장 통증 패치 시장 : 처방별(2020-2032년)

• 처방
• OTC

제10장 통증 패치 시장 : 환자 연령별(2020-2032년)

• 성인
• 소아

제11장 통증 패치 시장 : 점착 특성별(2020-2032년)

• 저알레르기성
• 표준

제12장 통증 패치 시장 : 작용 시간별(2020-2032년)

• 단시간 작용성
• 서방형

제13장 통증 패치 시장 : 약제 클래스별(2020-2032년)

• NSAID 패치
• 국소 마취 패치
• 기타

제14장 통증 패치 시장 : 유통 채널별(2020-2032년)

• 소매 약국
• 병원 및 클리닉

제15장 통증 패치 시장 : 지역별(2020-2032년)

• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 호주
  • 한국
  • ASEAN
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 중동
  • GCC
  • 이스라엘
  • 기타 중동
• 아프리카
  • 남아프리카
  • 중앙 아프리카
  • 북아프리카

제16장 경쟁 구도

• Hisamitsu Pharmaceutical Co., Inc.
• Johnson & Johnson
• Pfizer Inc.
• Novartis AG
• Mylan NV
• Endo Pharmaceuticals
• Teikoku Pharma USA, Inc.
• Acorda Therapeutics
• Ibsa Institut Biochimique SA
• Alembic Pharmaceuticals
• Noven Pharmaceuticals, Inc.
• Teva Pharmaceuticals
• Strativa Pharmaceuticals
• Galen Limited
• Napp Pharmaceuticals

제17장 섹션

• 조사 방법
• 출판사에 대해

AJY

영문 목차

영문목차

Pain Patch Market is estimated to be valued at USD 5.83 Bn in 2025 and is expected to reach USD 8.2 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 5.83 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.00%	2032 Value Projection:	USD 8.2 Bn

Pain patches, also known as transdermal patches, are adhesive patches that deliver medication directly through the skin to provide localized pain relief. These patches are convenient, easy to use, and offer a controlled release of medication over an extended period.

Market Dynamics:

The pain patch market is primarily driven by the increasing prevalence of chronic pain conditions, such as arthritis, back pain, and neuropathic pain. These conditions require long-term pain management solutions, and pain patches offer a convenient and effective option. Moreover, the rising awareness about the potential risks associated with oral pain medications, such as addiction and gastrointestinal side effects, is shifting the focus towards non-invasive drug delivery systems like pain patches.

However, the market growth may be hindered by certain factors. The high cost of pain patches compared to traditional pain medications and the limited availability of reimbursement for these products in some regions may restrict market expansion. Additionally, the stringent regulatory requirements for the approval of pain patches and the risk of skin irritation or allergic reactions associated with patch usage pose challenges to market growth.

Despite these challenges, the pain patch market presents several opportunities for growth. The increasing adoption of advanced technologies, such as wireless connectivity and sensor integration in pain patches, opens up avenues for innovation and product differentiation. Furthermore, the untapped potential of emerging markets and the growing demand for personalized pain management solutions provide opportunities for market players to expand their presence and cater to a diverse consumer base.

Key features of the study:

• This report provides in-depth analysis of the global pain patch market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global pain patch market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Pfizer Inc., Novartis AG, Mylan N.V., Endo Pharmaceuticals, Teikoku Pharma USA, Inc., Acorda Therapeutics, Ibsa Institut Biochimique SA, Alembic Pharmaceuticals, Noven Pharmaceuticals, Inc., Teva Pharmaceuticals, Strativa Pharmaceuticals, Galen Limited, and Napp Pharmaceuticals
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global pain patch market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain patch market

Detailed Segmentation:

• Global Pain Patch Market, By Type
  • Opioid Pain Patches
  • Non-Opioid Pain Patches
• Global Pain Patch Market, By Application
  • Chronic Pain Patches
  • Acute Pain Patches
• Global Pain Patch Market, By Technology
  • Traditional Drug Delivery Patches
  • Advanced Drug Delivery Patches
• Global Pain Patch Market, By Formulation
  • Single Medication Patches
  • Combination Therapy Patches
• Global Pain Patch Market, By Prescription
  • Prescription Pain Patches
  • Over-the-Counter (OTC) Pain Patches
• Global Pain Patch Market, By Patient Age
  • Adult Pain Patches
  • Pediatric Pain Patches
• Global Pain Patch Market, By Adhesive Properties
  • Hypoallergenic Patches
  • Standard Adhesive Patches
• Global Pain Patch Market, By Duration of Action
  • Short-Acting Patches
  • Extended-Release Patches
• Global Pain Patch Market, By Drug Class
  • NSAID Patches
  • Local Anesthetic Patches
  • Other Medication Patches
• Global Pain Patch Market, By Distribution Channel
  • Retail Pharmacies
  • Hospitals and Clinics
• Global Pain Patch Market, By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • Mylan N.V.
  • Endo Pharmaceuticals
  • Teikoku Pharma USA, Inc.
  • Acorda Therapeutics
  • Ibsa Institut Biochimique SA
  • Alembic Pharmaceuticals
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceuticals
  • Strativa Pharmaceuticals
  • Galen Limited
  • Napp Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet , By Type
  • Market Snippet , By Application
  • Market Snippet , By Technology
  • Market Snippet , By Formulation
  • Market Snippet , By Prescription
  • Market Snippet , By Patient Age
  • Market Snippet , By Adhesive Properties
  • Market Snippet , By Duration of Action
  • Market Snippet , By Drug Class
  • Market Snippet , By Distribution Channel
  • Market Snippet , By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing demand for effective pain relief and non-invasive treatment
  • Skin Sensitivity and Irritation
  • Emergence of Personalized Pain Management
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Pain Patch Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Pain Patch Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Opioid Pain Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Non-Opioid Pain Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Pain Patch Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Chronic Pain Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Acute Pain Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Pain Patch Market, By Technology, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Traditional Drug Delivery Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Advanced Drug Delivery Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Pain Patch Market, By Formulation, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Single Medication Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Combination Therapy Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Pain Patch Market, By Prescription, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Prescription Pain Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Over-the-Counter (OTC) Pain Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

10. Pain Patch Market, By Patient Age, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adult Pain Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Pediatric Pain Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

11. Pain Patch Market, By Adhesive Properties, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hypoallergenic Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Standard Adhesive Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

12. Pain Patch Market, By Duration of Action, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Short-Acting Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Extended-Release Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

13. Pain Patch Market, By Drug Class, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• NSAID Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Local Anesthetic Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Other Medication Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

14. Pain Patch Market, By Distribution Channel, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

15. Pain Patch Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • South Africa
    • Central Africa
    • North Africa

16. Competitive Landscape

• Hisamitsu Pharmaceutical Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Mylan N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Endo Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Teikoku Pharma USA, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Acorda Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Ibsa Institut Biochimique SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Alembic Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Noven Pharmaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Teva Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Strativa Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Galen Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Napp Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

17. Section

• Research Methodology
• About us

관련자료